STOCK TITAN

ProPhase Labs (NASDAQ: PRPH) secures $2,085,000 senior convertible loan

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ProPhase Labs, Inc. entered into a senior secured convertible loan agreement with J.J. Astor & Co. on July 31, 2026. The loan has an original principal amount of $2,085,000, provided in exchange for funding of $1,500,000 before agreed fees, reserves and other amounts.

The company received net proceeds of $1,020,000 at closing. The loan is payable in weekly installments and matures in accordance with the terms of the Loan Agreement, which also includes customary representations, covenants and events of default. The transaction is reported as a direct financial obligation, with the Loan Agreement and related note form filed as exhibits.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Loan principal $2,085,000 Original principal amount of senior secured convertible loan with J.J. Astor & Co.
Loan funding amount $1,500,000 Funding provided in exchange for the loan before fees, reserves and other amounts.
Net proceeds at closing $1,020,000 Cash received by ProPhase Labs at closing under the Loan Agreement.
senior secured convertible loan financial
"providing for a senior secured convertible loan in the original principal amount of $2,085,000"
material definitive agreement regulatory
"Item 1.01. Entry into a Material Definitive Agreement."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
events of default financial
"The Loan Agreement contains customary representations and warranties, affirmative and negative covenants, and events of default."
Events of default are specific breaches or failures listed in a loan, bond, or credit agreement that give lenders the right to act, such as demanding immediate repayment, raising interest rates, or taking secured assets. They matter to investors because triggering one is like setting off a financial alarm: it raises the chance of foreclosure, restructuring, or bankruptcy and can sharply reduce the value of a company’s stock or bonds and increase borrowing costs.
direct financial obligation regulatory
"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement"
weekly installments financial
"The loan is payable in weekly installments and matures in accordance with the terms set forth"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What financing agreement did ProPhase Labs (PRPH) enter on July 31, 2026?

ProPhase Labs entered a Loan Agreement with J.J. Astor & Co. for a senior secured convertible loan. The loan carries $2,085,000 in original principal and is structured with weekly installment payments and standard covenants and events of default.

What is the principal amount of the new ProPhase Labs (PRPH) loan?

The new senior secured convertible loan for ProPhase Labs has $2,085,000 in original principal. This principal was issued in exchange for $1,500,000 in funding before agreed fees, reserves and other deductions specified in the Loan Agreement.

How much cash did ProPhase Labs (PRPH) receive from the J.J. Astor & Co. loan?

ProPhase Labs received net proceeds of $1,020,000 at closing under the Loan Agreement. This amount reflects the $1,500,000 funding less agreed fees, reserves and other amounts described in the senior secured convertible loan terms.

Who is the lender in ProPhase Labs (PRPH) new senior secured convertible loan?

The lender for ProPhase Labs’ new senior secured convertible loan is J.J. Astor & Co.. The agreement establishes J.J. Astor & Co. as the counterparty providing $1,500,000 in funding against $2,085,000 principal, subject to customary covenants and default provisions.

How will ProPhase Labs (PRPH) repay the new loan from J.J. Astor & Co.?

The senior secured convertible loan is payable in weekly installments and matures as detailed in the Loan Agreement. Repayment terms are combined with customary representations, affirmative and negative covenants, and defined events of default governing the company’s ongoing obligations.
false 0000868278 0000868278 2026-07-31 2026-07-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 31, 2026

 

PROPHASE LABS, INC.

(Exact name of Company as specified in its charter)

 

Delaware   000-21617   23-2577138

(State or other jurisdiction

of incorporation )

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

626 RXR Plaza, 6th Floor

Uniondale, New York

  11556
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (516) 989-0763

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14(d)-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities Registered Pursuant to Section 12(b) of the Exchange Act:

 

Title of Each Class   Trading Symbol   Name of Each Exchange of Which Registered
Common Stock, par value $0.0005   PRPH   OTC ID

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On July 31, 2026, ProPhase Labs, Inc. (the “Company”) entered into a Loan Agreement with J.J. Astor & Co. (the “Lender”) providing for a senior secured convertible loan in the original principal amount of $2,085,000 in exchange for funding of $1,500,000, before the deduction of agreed-upon fees, reserves and other amounts provided for in the Loan Agreement. The Company received net proceeds at closing of $1,020,000 in accordance with the terms of the Loan Agreement. The loan is payable in weekly installments and matures in accordance with the terms set forth in the Loan Agreement.

 

The Loan Agreement contains customary representations and warranties, affirmative and negative covenants, and events of default.

 

The foregoing description of the Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the Loan Agreement, which is filed as Exhibit 10.1 to this Current Report and is incorporated herein by reference.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth under Item 1.01 of this Current Report is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

10.1Loan Agreement, dated July 31, 2026, by and between ProPhase Labs, Inc. and J.J. Astor & Co.
10.2Form of $2,085,000 senior secured installment promissory note of ProPhase Labs, Inc.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ProPhase Labs, Inc.  
     
By: /s/ Ted Karkus  
  Ted Karkus  
  Chairman of the Board and Chief Executive Officer  
     
Date: August 06, 2026  

 

 

 

Filing Exhibits & Attachments

5 documents